KRYS moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend. In 31 of 39 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 79%.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KRYS as a result. In 80 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for KRYS turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In 39 of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
The 10-day moving average for KRYS crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 63%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KRYS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for KRYS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 40 of 54 cases where KRYS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
Following a +2.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where KRYS advanced for three days, in 260 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
KRYS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. KRYS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.972) is normal, around the industry mean (2.973). P/E Ratio (38.710) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (23.202) is also within normal values, averaging (438.009).
TGTX saw its Momentum Indicator move below the 0 level on October 22, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 70 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 88%.
The Moving Average Convergence Divergence Histogram (MACD) for TGTX turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 34 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
TGTX moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TGTX crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TGTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 64 cases where TGTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
Following a +3.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where TGTX advanced for three days, in 254 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
TGTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 179 of 210 cases where TGTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The Tickeron SMR rating for this company is 14 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. TGTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 60 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.470) is normal, around the industry mean (2.973). P/E Ratio (17.373) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (11.136) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
KRYS | TGTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 6 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 9 | 60 | |
SMR RATING 1..100 | 46 | 14 | |
PRICE GROWTH RATING 1..100 | 42 | 42 | |
P/E GROWTH RATING 1..100 | 37 | 96 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TGTX's Valuation (90) in the Biotechnology industry is in the same range as KRYS (92) in the Pharmaceuticals Major industry. This means that TGTX’s stock grew similarly to KRYS’s over the last 12 months.
KRYS's Profit vs Risk Rating (9) in the Pharmaceuticals Major industry is somewhat better than the same rating for TGTX (60) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than TGTX’s over the last 12 months.
TGTX's SMR Rating (14) in the Biotechnology industry is in the same range as KRYS (46) in the Pharmaceuticals Major industry. This means that TGTX’s stock grew similarly to KRYS’s over the last 12 months.
TGTX's Price Growth Rating (42) in the Biotechnology industry is in the same range as KRYS (42) in the Pharmaceuticals Major industry. This means that TGTX’s stock grew similarly to KRYS’s over the last 12 months.
KRYS's P/E Growth Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for TGTX (96) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than TGTX’s over the last 12 months.
| KRYS | TGTX | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 74% | 1 day ago 88% |
| Momentum ODDS (%) | 1 day ago 75% | 1 day ago 88% |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 79% |
| TrendWeek ODDS (%) | 1 day ago 68% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 70% | 1 day ago 80% |
| Advances ODDS (%) | 3 days ago 80% | 8 days ago 84% |
| Declines ODDS (%) | 1 day ago 71% | 1 day ago 83% |
| BollingerBands ODDS (%) | 1 day ago 84% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 66% | 1 day ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KRYS’s FA Score shows that 1 FA rating(s) are green while TGTX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KRYS’s TA Score shows that 3 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).
KRYS (@Biotechnology) experienced а -2.99% price change this week, while TGTX (@Biotechnology) price change was -5.07% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
KRYS is expected to report earnings on Nov 02, 2026.
TGTX is expected to report earnings on Nov 02, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ARQT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ARQT could also see price increases.
| Ticker / NAME | Correlation To TGTX | 1D Price Change % | ||
|---|---|---|---|---|
| TGTX | 100% | -0.08% | ||
| ARQT - TGTX | 39% Loosely correlated | +1.04% | ||
| PTGX - TGTX | 38% Loosely correlated | +1.05% | ||
| KRYS - TGTX | 37% Loosely correlated | -0.63% | ||
| ARRY - TGTX | 36% Loosely correlated | -3.23% | ||
| PTCT - TGTX | 36% Loosely correlated | +0.67% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BTO | 37.37 | 0.72 | +1.96% |
| John Hancock Financial Opportunities Fund | |||
| UPSX | 9.07 | 0.12 | +1.34% |
| Tradr 2X Long UPST Daily ETF (UPSX) | |||
| HTAB | 18.33 | 0.17 | +0.94% |
| Hartford Schroders Tax-Aware Bond ETF (HTAB) | |||
| KDEC | 28.11 | 0.01 | +0.03% |
| Innovator U.S. Small Cap Power Buffer ETF - December (KDEC) | |||
| VOT | 289.24 | -4.59 | -1.56% |
| Vanguard Morningstar Mid-Cap Growth ETF (VOT) | |||